2023Theoretical and Natural ScienceOpen access

Antiviral Resistance in Influenza Virus: Mechanism of Action

Weichen Lyu

Open full text 0 citations

Abstract

The "Spanish flu" pandemic caused by H1N1 virus in 1918 caused 50 million deaths. The best-known drugs for treating influenza viruses are antiviral drugs, including amantadine, rimantadine, zanamivir, and oseltamivir. Amantadine and rimantadine are excellent prophylactic drugs against influenza A. Whereas, Zanamivir and oseltamivir have comparable efficacy against influenza A and B viruses. This paper reviews antiviral drugs, approved for clinical use. This review evaluates neuraminidase inhibitors (NAIs), focusing on their mechanism of action and the emergence of resistance to them. The results showed that the viruses mutated and developed resistance during the treatment with NAIs for seasonal, pandemic, and avian influenza

Open-access reader

About this research paper

What this paper is about

The "Spanish flu" pandemic caused by H1N1 virus in 1918 caused 50 million deaths. The best-known drugs for treating influenza viruses are antiviral drugs, including amantadine, rimantadine, zanamivir, and oseltamivir. Amantadine and rimantadine are excellent prophylactic drugs against influenza A. Whereas, Zanamivir and oseltamivir have comparable efficacy against influenza A and B viruses. This paper reviews antiviral drugs, approved for clinical use. This review evaluates neuraminidase inhibitors (NAIs), focusing on their mechanism of action and the emergence of resistance to them. The results showed that the viruses mutated and developed resistance during the treatment with NAIs for seasonal, pandemic, and avian influenza

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The "Spanish flu" pandemic caused by H1N1 virus in 1918 caused 50 million deaths. The best-known drugs for treating influenza viruses are antiviral drugs, including amantadine, rimantadine, zanamivir, and oseltamivir. Amantadine and rimantadine are excellent prophylactic drugs against influenza A. Whereas, Zanamivir and oseltamivir have comparable efficacy against influenza A and B viruses. This paper reviews antiviral drugs, approved for clinical use. This review evaluates neuraminidase inhibitors (NAIs), focusing on their mechanism of action and the emergence of resistance to them. The results showed that the viruses mutated and developed resistance during the treatment with NAIs for seasonal, pandemic, and avian influenza

Key concepts: Rimantadine, Zanamivir, Amantadine, Oseltamivir, Neuraminidase, Virology, Neuraminidase inhibitor, Virus

Related papers

Back to paper searchBrowse research topicsOriginal source
Antiviral Resistance in Influenza Virus: Mechanism of Action — Research Paper | ScholarLens